Annual report pursuant to Section 13 and 15(d)

Note 21 - Segment Information: Reconciliation of Revenue from Segments to Consolidated (Details)

v3.21.1
Note 21 - Segment Information: Reconciliation of Revenue from Segments to Consolidated (Details) - USD ($)
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Details    
Segment Reconciliation, Operating Loss $ (1,074,104) $ (1,745,943)
Segment Reconciliation, Gain (Loss) on Investments (14,961) (78,649)
Gain on sale of GlauCanna rights 31,000 0
Impairment of investments (139,148) (1,688,825)
Segment Reconciliation, Interest income 92,571 108,113
Segment Reconciliation, Interest Expense (35,295) (22,596)
Segment Reconciliation, Gain (loss) on investments 67 2,200
PPP loan forgiven 452,348 0
EIDL Grant 10,000 0
Segment Reconciliation, Other income (expense) 10,031 21,896
Segment Reconciliation, Income before income taxes $ (667,491) $ (3,403,804)